General surgery
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age= 18 years old = 75 years old, and gender is not limited; 2. Minimally invasive gastrectomy (radical gastrectomy, partial gastrectomy), bowel resection (radical colorectal resection) and cholecystectomy are planned; 3. For gastric cancer patients, it is necessary to meet: (1) primary gastric cancer stage I./II./III.; (2) Clinical and imaging examinations without distant metastases such as liver or lungs; 4. For colorectal cancer patients, preoperative diagnosis is required for stage I./II./III. colorectal cancer; 5. Patients fully understand the benefits and risks of this trial, and are willing to participate in this trial and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Have severe heart, lung, brain, liver and kidney diseases, unable to tolerate surgery or anesthesia; 2. Inability to tolerate pneumoperitoneum; 3. Severe anemia, coagulation dysfunction; 4. Patients with active tuberculosis; 5. Extensive metastasis in the abdomen-pelvic cavity of the tumor; 6. Colorectal cancer obstruction with obvious abdominal distention; 7. Emergency surgery such as acute obstruction, perforation, and heavy bleeding of tumors; 8. Tumor perforation combined with acute peritonitis; 9. Extensive and severe adhesions in the abdominal cavity, etc., resulting in the inability to puncture to establish pneumoperitoneum, and difficult to separate the storm exposed lesions; Includes history of major abdominal surgery and abdominal radiotherapy, as judged by the investigator Situations where there is a risk of extensive adhesions; 10. Physical failure, massive abdominal effusion, internal bleeding or shock; 11. Gastric cancer lymph node metastases fuse and enclose important blood vessels; 12. Pregnant and lactating women; 13. Severe obesity with BMI = 30 kg/m2; 14. Those with a history of epilepsy or psychiatric illness or cognitive impairment; 15. Participated in clinical trials of other drugs or devices within 3 months before surgery; 16. Other conditions deemed unsuitable by the investigator to participate in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Surgical success rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood loss;Operation time;Hospital stays;Postoperation pain score;Surgeon's satisfaction socre ;Blood transfusion rate; | — |
Countries
China
Contacts
Ruijin Hospital, Shanghai Jiaotong University School of Medicine